Cassie Lane

Cassie Lane is currently a Senior Clinical Scientist at Bristol Myers Squibb, a position held since July 2024 following the acquisition of Mirati Therapeutics. Prior to this role, Cassie served as a Senior Director and Director of Clinical Development Science at Mirati Therapeutics from December 2021 to July 2024. Cassie's extensive experience includes a tenure at Sarah Cannon, where roles included Director and Senior Manager of Clinical Development, as well as Senior Program Manager from September 2016 to December 2021. Cassie began a career at Sarah Cannon Research Institute, progressing through various positions including Program Manager and Clinical Research Specialist between December 2007 and September 2016. Cassie holds a Master of Science in Research and Experimental Psychology and a Bachelor of Science in Biology and Psychology, both degrees obtained from The University of Tennessee at Chattanooga.